The only evidence available in the cord blood transplantation setting is a recent registry study ( 14 ), which showed a trend to reduced AML relapse in patients with CMV reactivation.
← all excerpts
Potential Beneficial Effects of Cytomegalovirus Infection after Transplantation.
1
—
—